Previous Article | Next Article ![]()
Applied and Environmental Microbiology, February 2000, p. 535-542, Vol. 66, No. 2
Department of Medical Microbiology, Academic
Medical Center, University of Amsterdam, 1105 AZ
Amsterdam,1 and Department of Genetics,
Center for Biological Sciences, University of Groningen, 9751 NN
Haren,2 The Netherlands
Received 23 August 1999/Accepted 30 November 1999
Viridans group streptococci are major constituents of the normal
human oral flora and are also identified as the predominant pathogenic
bacteria in native valve infective endocarditis. Little information is
available regarding the regulation of gene expression in viridans group
streptococci, either in response to changes in the oral environment or
during development of endocarditis. We therefore constructed a set of
broad-host-range vectors for the isolation of promoters from viridans
group streptococci that are activated by specific environmental stimuli
in vitro or in vivo. A genomic library of Streptococcus
gordonii strain CH1 was constructed in one of the new vectors,
and this library was introduced into a homologous bacterium by using an
optimized electroporation protocol for viridans group streptococci.
Because viridans group streptococci entering the bloodstream from the
oral cavity encounter an increase in pH, we selected promoters
upregulated by this specific stimulus. One of the selected promoter
sequences showed homology to the promoter region of the
hydA gene from Clostridium acetobutylicum, the
expression of which is known to be regulated by the environmental pH.
The isolation of this pH-regulated promoter shows that S. gordonii can sense an increase in the environmental pH, which serves as a signal for bacterial gene activation. Furthermore, this
demonstrates the usefulness of these new selection vectors in research
on adaptive gene expression of viridans group streptococci and possibly
also of other gram-positive bacteria.
Viridans group streptococci (VS) are
major constituents of the human commensal oral flora (15).
They constantly have to adapt to the rapid changes in their natural
habitat (4). Adaptation is characterized firstly by sensing
of environmental changes, followed by signal transduction, which can
result in the expression of genes whose products are involved in the
adaptive process (17, 30, 43). One of the environmental
changes VS encounter is variation in the extracellular pH, which drops
rapidly after carbohydrate consumption by the host. Streptococcus
mutans responds to such a decrease in pH by rapid upregulation of
the expression of several regulatory genes and of genes involved in
stress responses, including hcrA, grpE, and
dnaK (23). However, knowledge on gene expression in other VS induced by pH or other environmental stimuli is scarce.
VS, including Streptococcus sanguis, Streptococcus
oralis, and Streptococcus gordonii, are the most
frequently encountered bacterial causes of native valve infective
endocarditis (IE) (10, 40). This disease is caused by the
rapid growth and persistence of bacteria embedded in a platelet-fibrin
thrombus (a vegetation) present on damaged endocardium or heart valves
(12). Studies on virulence factors of VS in the pathogenesis
of IE have mainly focused on components involved in bacterial adherence
to the vegetation. These include exopolysaccharides (7, 31)
and adhesins for connective-tissue proteins, for adhesive
macromolecules present in plasma, and for blood platelets (3, 19,
25, 47). Little information is available on the regulation of
these and other possible virulence factors of VS in the host.
Therefore, we have developed a plasmid-based selection system for the
isolation of inducible VS promoters. The system is designed partly in
analogy to the in vivo expression technology (IVET) system (18,
28), since IVET has been shown to be a promising tool in the
study of adaptive gene expression of VS in an experimental rabbit model
of IE [20; A. O. Kiliç, M. C. Herzberg, X. Zhao, M. W. Meyer, and L. Tao, Abstr. ASM Conf.
Streptococcal Genet. (Genet. Streptococci, Enterococci, Lactococci),
abstr. LB-03, p. 41, 1998]. As VS experience an increase in the
environmental pH from slightly acidic to neutral levels when entering
the blood from the oral plaque (33), we used this selection
system to identify genes whose expression was influenced by this
specific stimulus. A pH-regulated promoter of S. gordonii
strain CH1 was isolated and characterized, showing that VS indeed
recognize an increase in pH as a signal for adaptive gene expression.
Bacterial strains, plasmids, and growth conditions.
Bacterial strains and plasmids used in this study are listed in Tables
1 and 2,
respectively. Escherichia coli strains BHB2600 and DH5
0099-2240/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Broad-Host-Range Shuttle Vectors for Screening of Regulated
Promoter Activity in Viridans Group Streptococci: Isolation of a
pH-Regulated Promoter
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
were cultured in Luria-Bertani broth and on Luria-Bertani agar at
37°C. For maintenance of plasmids, ampicillin (50 µg/ml) or
erythromycin (150 µg/ml for strain BHB2600 and 300 µg/ml for strain
DH5
) was added to the growth medium. VS were cultured in Todd-Hewitt
(TH) broth and on TH agar (Difco Laboratories, Detroit, Mich.) at
37°C in a 5% CO2 atmosphere or anaerobically. When
required, TH broth and TH agar were supplemented with erythromycin (5 µg/ml).
TABLE 1.
Bacterial strains used in this study
TABLE 2.
Plasmids used in this study
MIC and MBC determination. The MICs and minimal bactericidal concentrations (MBCs) of spectinomycin for VS were determined by broth microdilution assays (32). Dilution series of spectinomycin or kanamycin, ranging from 25 to 1,000 µg/ml, in TH broth supplemented with 5% horse blood were prepared in microtiter plates. To each well 100 µl of TH broth containing 106 bacteria was added, and the plates were incubated overnight at 37°C in a 5% CO2 atmosphere. The MIC was defined as the lowest antibiotic concentration at which no growth was visible. To determine the MBC, 1 µl from each well without visible bacterial growth was cultured on blood agar plates. The MBC was defined as the lowest antibiotic concentration that reduced the bacterial inoculum at least 1,000-fold.
DNA isolation. Plasmid DNA was isolated from E. coli using Qiagen GmbH (Hilden, Germany) plasmid DNA isolation kits and was isolated from VS as described previously (52). Chromosomal DNA from VS was isolated using the Puregene chromosomal DNA isolation kit for gram-positive bacteria and yeast (Gentra Systems Inc., Minneapolis, Minn.).
Molecular cloning and DNA sequence determination. DNA manipulations were done according to standard techniques (39). Plasmid DNA was introduced into E. coli by electroporation using the method of Dower et al. (11). DNA sequencing was performed with the PCR-mediated Taq Dye Deoxy Terminator Cycle sequencing kit (Perkin-Elmer, Foster City, Calif.) using an Applied Biosystems model 373 DNA sequencer.
Construction of selection vectors pMM223 and pMM225. Plasmids used for the construction of the selection vectors pMM223 and pMM225 are listed in Table 2. The 3.3-kb BamHI-HindIII fragment of pEC2A (5), containing the promoterless trp'-'lacZ fusion gene (9), was ligated to the EcoRI-BamHI part of the pIC20R multiple cloning site (MCS) (29) and the product was introduced into the EcoRI- and HindIII-digested shuttle vector pMG36e (49), resulting in pMM201 (data not shown). To achieve higher cloning efficiencies, the MCS-trp'-'lacZ fragment was excised from pMM201 as an EcoRI-KpnI fragment and ligated to EcoRI- and KpnI-digested E. coli plasmid pLITMUS28 (14), creating pMM210 (Fig. 1). Self-annealed primer AV7 (Table 3) was cloned into the KpnI site of pMM210, replacing this site by an SpeI site (pMM211). The gene aad(9), originating from Enterococcus faecalis and conferring resistance to spectinomycin (27), was amplified as a promoterless gene from plasmid pORI19S (H. E. Smith, personal communication) using primers AV3 and AV4 (Table 3). The 795-bp PCR fragment was digested with BamHI and cloned into the BamHI site of pMM211, resulting in pMM214. A bidirectional transcriptional terminator of Streptococcus equisimilis H46A present on a 922-bp PstI-HindIII fragment of plasmid pSU31 (45) was amplified using primers AV8 and AV9 (Table 2). The terminator fragment was digested with SpeI and EcoRI and ligated in the reversed orientation in front of the selection cassette of pMM214 to generate plasmid pMM218 (Fig. 1). For the construction of the second selection cassette, the aphIII gene originating from E. faecalis plasmid pJH1 and conferring resistance to kanamycin (48) was selected. It was amplified from plasmid pMG36 (49) as a promoterless gene by using primers AV1 and AV2 (Table 3). The 855-bp product was digested with BamHI and used to replace the BamHI fragment of pMM218 comprising the promoterless aad(9) gene. The resulting plasmid was designated pMM219. The selection cassettes were excised as SpeI fragments from pMM218 and pMM219 and ligated to XbaI-digested pMM206, a derivative of the lactococcal shuttle vector pGKV210 (50), to yield the vectors pMM223 [aad(9) Sp] and pMM225 (aphIII Km), respectively (Fig. 1).
|
|
Electrotransformation of VS.
Electrocompetent VS cells were
prepared according to the method of Smith et al. (44), with
minor modifications. Briefly, bacteria harvested from mid-log cultures
in TH broth were washed three times in ice-cold, sterile distilled
water and three times in ice-cold 0.3 M sucrose-10% glycerol.
Bacteria were resuspended in 1/500 volume of the latter solution, and
50 µl of this suspension was used for electroporation with a
Gene-Pulser and Pulse Controller (Bio-Rad Laboratories B.V.,
Veenendaal, The Netherlands). Immediately after electroporation, 0.95 ml of TH broth supplemented with 0.3 M sucrose was added, and the
bacteria were incubated for 2 h at 37°C and subsequently
plated on the appropriate selective agar medium. Colonies of VS
transformants were visible after 24 to 48 h of incubation at
37°C in a 5% CO2 atmosphere. To obtain maximal transformation frequencies, cuvettes with different electrode gap sizes
(0.1 or 0.2 cm) were tested, and resistance setting (100 or 200
),
field strength (10 to 25 kV/cm), and type of electrical pulse (decayed
pulse or squared pulse) were varied. In addition, the influence of
procedures affecting VS cell wall integrity on electroporation
efficiencies was tested. DL-Threonine (40 mM), 1%
(vol/vol) glycine, or a sub-MIC concentration of penicillin G was added
to the growth medium used for the preparation of competent VS cells, or
competent VS were enzymatically treated with lysozyme (0.5 mg/ml; Sigma
Chemical Co., St. Louis, Mo.) and mutanolysin (2.5 U/ml; Sigma) for
1 h.
Natural transformation of S. gordonii CH1. S. gordonii CH1 cells were made competent for natural transformation according to the method of Jenkinson (24). Briefly, an overnight culture in brain heart yeast (brain heart infusion medium [Difco Laboratories] with 5 g of yeast extract [Difco] per liter) was diluted 100-fold in fresh brain heart yeast supplemented with 5% horse serum and 1% glucose and then incubated for 3 h at 37°C. This culture was diluted 100-fold in fresh medium and incubated for 1 h at 37°C. From this culture 1-ml aliquots were taken, 1.5 µg of plasmid DNA was added, and incubation was continued for another 3 h at 37°C. Aliquots of 10 µl were plated onto selective TH agar and incubated for 24 to 48 h at 37°C in a 5% CO2 atmosphere to select for plasmid-containing transformants.
-Galactosidase activity assay.
-Galactosidase
activities of the VS clones were determined using the fluorescent
substrate fluorescein di-
-galactopyranoside (FDG; Molecular Probes
Europe BV, Leiden, The Netherlands). Bacteria cultured overnight in TH
broth containing erythromycin (5 µg/ml) were harvested by
centrifugation, washed, and resuspended in STES buffer (10 mM Tris-HCl,
100 mM NaCl, 1 mM EDTA, 20% sucrose) to an optical density at 620 nm
(A620) of 1.0. Of this suspension 1.5 ml was
centrifuged, the pellet was resuspended in 1 ml of STES buffer
supplemented with 50 mg of lysozyme per ml and 200 U of mutanolysin per
ml, and this suspension was incubated at 37°C. After 2 h, 50 µl of 1% sodium dodecyl sulfate and 50 µl of chloroform were added
and the samples were mixed for 10 s and then were left standing
for 15 min at room temperature. Six replicate samples of 50 µl of
this suspension were transferred to wells of microtiter plates, 150 µl of Z buffer (40 mM NaH2PO4, 60 mM Na2HPO4, 10 mM KCl, 1 mM MgSO4, 40 mM
-mercaptoethanol [pH 7.0]) containing 33 µM FDG was added to
each replicate, and microtiter plates were incubated at 37°C. The
emission was measured at different times at 530 nm (band-pass
wavelength = 30 nm) after excitation at 485 nm (band-pass
wavelength = 20 nm) using a Cytofluor II fluorescence multiwell
plate reader (PerSeptive Biosystems, Inc., Framingham, Mass.). The
-galactosidase activity was plotted as arbitrary fluorescence units
over time, and results are the averages of six reactions.
Construction of an S. gordonii CH1 genomic library. A genomic library of S. gordonii CH1 was constructed using the selection vector pMM223. Vector DNA was digested with BglII and dephosphorylated using calf intestine alkaline phosphatase (Boehringer Mannheim GmbH, Mannheim, Germany). Genomic DNA isolated from S. gordonii CH1 was digested to completion with Sau3A. Vector and chromosomal fragments were ligated, and the ligation mixture was introduced into E. coli BHB2600 by electroporation. Plasmid DNA was isolated from erythromycin-resistant transformants constituting the genomic library and introduced into the homologous streptococcal strain CH1 by electroporation.
Selection of pH-regulated promoters. The streptococcal genomic bank was plated onto TH agar of pH 7.3 supplemented with erythromycin (5 µg/ml) for plasmid maintenance and spectinomycin (500 µg/ml) for selection of active streptococcal promoters. After anaerobic incubation at 37°C for 36 h, colonies resistant to erythromycin as well as spectinomycin were replated onto TH agar of pH 6.2 supplemented with erythromycin and spectinomycin. As a control for the viability of the isolated S. gordonii clones, these were also restreaked onto TH agar plates of pH 6.2 supplemented with erythromycin only and onto plates of pH 7.3 supplemented with erythromycin and spectinomycin. Plasmids were isolated from clones that failed to grow on the pH 6.2 agar but that did grow on the agar of pH 7.3 in the presence of spectinomycin. The fragments cloned in these plasmids were amplified by PCR using primers AV4 and AV9 (Table 3), and the PCR products were sequenced using primer AV19 (Table 3). The obtained sequences were analyzed using the BLAST program (2).
Measurement of in vitro growth rate.
To determine the
relative activities of promoters at different pH values, the growth
rates of selected clones were determined in TH broth of pH 6.2 and pH
7.3, in the presence and absence of spectinomycin. A single colony of
each clone was cultured at 37°C in TH broth supplemented with
erythromycin for plasmid maintenance. Overnight cultures were diluted
100-fold in fresh TH broth containing both erythromycin (5 µg/ml) and
spectinomycin (500 µg/ml) or containing erythromycin alone. Growth
was monitored by measuring the A620 over time,
and the mid-log-phase doubling time (t1/2) was determined. Relative promoter activity at pH 6.2 and 7.3 was expressed as the ratio of growth in the presence and absence of spectinomycin at
each pH [t1/2
(+spec)/t1/2(
spec)].
Statistical evaluation. The significance of the differences between the growth rate ratios at either pH was calculated with Student's t test.
Nucleotide sequence accession numbers. The sequences of the vectors pMM223 and pMM225 have been assigned GenBank accession numbers AF076212 and AF076213, respectively. The sequence of the isolated pH-regulated promoter fragment from S. gordonii CH1 pMM243 has been assigned GenBank accession number AF127175.
| |
RESULTS |
|---|
|
|
|---|
New broad-host-range promoter selection vectors pMM223 and
pMM225.
We constructed a set of self-replicating
broad-host-range promoter selection vectors for gram-positive
bacteria (Fig. 1). Firstly, selection cassettes were
constructed in E. coli plasmid pLITMUS28 (14).
Each selection cassette contains two promoterless genes. The first gene
is either a promoterless aphIII gene (48), conferring resistance to kanamycin, or an aad(9)
(27) gene, conferring resistance to spectinomycin, for the
selection of active promoters. The second gene is the
trp'-'lacZ fusion gene, encoding
-galactosidase
(9), to be used for discrimination between constitutive and
induced promoter activities. In front of the two promoterless genes,
the MCS from pIC20R (29) was introduced for insertion of DNA
fragments with possible promoter activity. A bidirectional
transcriptional terminator from S. equisimilis strain H46A
(45) was cloned in front of the MCS to prevent possible readthrough into the promoterless cassette. The terminator was inserted
in its reversed orientation, which has the highest termination activity
in E. coli TG1 (45). The resulting selection
cassettes have a total size of approximately 4.3 kb, and all components of the cassettes can be replaced or removed separately or in
combination, using common restriction endonucleases (Fig. 1).
Transformation of VS.
We optimized the electroporation
procedure using our standard S. sanguis test strain U108 and
shuttle vector pGKV210. Maximal efficiencies were obtained using
cuvettes with a 0.1-cm electrode gap at a resistance setting of 100
, a capacitance of 25 µF, and a field strength of 25 kV/cm (Fig.
2). At these settings time constants
ranged from 2.0 to 2.5 ms. The number of transformants increased
linearly with the plasmid DNA concentration over a range from 5 to 500 ng (data not shown). Despite the high field strength, survival rates of
S. sanguis U108 generally were 70% or higher. Colonies of
the U108 transformants were often variable in size, but the introduced
plasmid pGKV210 could be isolated from the transformants in all cases.
|
|
Testing of expression vectors. To determine the spectinomycin level required for the selection of active promoters, plasmid pMM239 was constructed. A 1.1-kb rgg-gtfG promoter fragment (46) amplified from the genomic DNA of S. gordonii CH1 using primers AV13 and AV16 was digested with BglII and PstI and then cloned into the MCS of pMM223. The MICs and MBCs for S. gordonii CH1 and S. sanguis U108 harboring either plasmid pMM223 or pMM239 were assessed. The presence of the active gtfG promoter in pMM239 was well detectable, since without plasmid or with pMM223 both strains were susceptible to spectinomycin concentrations of <25 µg/ml, whereas S. gordonii CH1 and S. sanguis U108 harboring pMM239 were resistant to >1,000 and >800 µg of spectinomycin per ml, respectively. The MICs of kanamycin for our test strains, S. gordonii CH1 and S. sanguis U108 with or without pMM225, were relatively high, 250 µg/ml, but the presence of an active promoter in pMM225 increased the level of resistance to >1,000 mg of kanamycin per ml. Thus, vectors pMM223 and pMM225 allowed selection of active promoters.
Subsequently, we evaluated the functionality of the promoterless lacZ reporter gene. In E. coli, promoter activity could easily be detected by plating the organism on agar plates containing 40 µg of 5-bromo-4-chloro-3-indolyl-
-D-galactoside (X-Gal) per ml
as a substrate. In S. gordonii CH1, the presence of an
active promoter could not be discriminated using either agar plates or agar overlays containing up to 500 µg of X-Gal per ml (1). All strains, carrying vectors with or without active promoters, produced blue colonies after 2 to 3 days of incubation. In liquid assays using FDG the presence of the rgg-gtfG promoter on
plasmid pMM239 could be detected in S. gordonii CH1 after
20 h of incubation, despite the endogenous
-galactosidase
activity (Fig. 3). Although addition of
2% glucose to the growth medium reduced this endogenous activity, it
did not improve the ability to detect an active promoter (data
not shown).
|
Selection of pH-regulated promoters of S. gordonii CH1. A genomic library of S. gordonii CH1 was constructed in pMM223 by using E. coli as an intermediate host, since direct transformation of ligation mixtures to S. gordonii CH1 resulted in low numbers of recombinant clones. We used pMM223 because the background resistance of S. gordonii CH1 to spectinomycin was very low (see above). The final streptococcal genomic library contained approximately 105 independent clones, with an average insert size of approximately 500 bp. Statistically, this library represents the entire genome of S. gordonii CH1 (39).
VS causing IE translocate from the oral plaque to the blood, and the bacteria are exposed to a pH shift from pH 6.0 to 6.5 (33) to pH 7.3 to 7.4. Therefore, we selected promoters which were upregulated at pH 7.3. Of 143 individual clones that grew on TH agar of pH 7.3 supplemented with 500 µg of spectinomycin per ml, 5 clones were identified which hardly grew on TH agar of pH 6.2 when spectinomycin was present. The pH of the medium influenced the activity of
-galactosidase (data not shown), hampering assessment of relative
promoter activity. Therefore, the promoter activities of one of these
clones [CH1(pMM243] at pH 6.2 and 7.3 were further tested by
determination of the in vitro growth rate in the presence or absence of
spectinomycin. The growth rate was significantly higher at pH 7.3 than
at pH 6.2 (0.94 ± 0.01 and 0.69 ± 0.04, respectively [P = 0.0005] as compared to a clone [CH1(pMM240)] that harbors a
constitutive streptococcal promoter (0.98 ± 0.01 and 0.95 ± 0.01 at
pH 7.3 and pH 6.2, respectively), demonstrating the upregulation of the
pH-regulated promoter at pH 7.3.
Sequencing of the pH-regulated promoter fragment and comparison to
GenBank sequences revealed homology to the promoter region of the
hydA gene of Clostridium acetobutylicum (Fig.
4). The
35 and
10 regions were
identified at almost identical positions in the two sequences. The
extended
10 sequence present in the clostridial hydA
promoter region (5'-AatATga-3') (lowercase letters represent
nucleotides that were not conserved in the extended
10
region)(54) was found at the same position upstream of the
10 box of the streptococcal promoter. The inverted repeat
sequences present upstream and downstream of the
Clostridium promoter stretch, involved in catabolite
repression (13, 16) and repression of the transcription of
hydA (16, 51), respectively, were, however, not
identified in the streptococcal sequence. A possible Shine-Dalgarno
sequence and translation start were found (Fig. 4). The cloned fragment
contained only the sequence encoding the first 24 amino acids of the
putative coding region following this translation start. This sequence
did not show homology to any entry in the GenBank database or to the
partly sequenced genomes of S. mutans, Streptococcus
pneumoniae, and Streptococcus pyogenes.
|
| |
DISCUSSION |
|---|
|
|
|---|
Apart from being important colonizers of the oral cavity and upper pharyngeal tract in humans, VS are recognized as the most common bacterial agents causing native valve IE (10, 40). Little information is available regarding the adaptive potential of this group of microorganisms, either in their natural habitat or during the pathogenesis of IE. Of techniques to study adaptive gene expression (38), the IVET system is most suited for selection of promoters of genes induced under specific in vitro conditions or in the complex in vivo environment (28). In its original design, the IVET system used integration of a nonreplicative vector into genomic DNA via a single crossover. This approach requires high frequencies of transformation, which are difficult to achieve in many gram-positive bacteria. In addition, although the IVET system was originally developed to not disrupt any bacterial genes (28), integration of a nonreplicative vector containing a fragment without a promoter may still cause mutations. We therefore developed an IVET-based selection-reporter system using self-replicating plasmids to study inducible genes in VS. Promoterless genes conferring resistance to kanamycin (aphIII) and spectinomycin [aad(9)] were chosen for the selection of active promoters, as these antibiotics are bactericidal for our VS (data not shown). The use of bacteriostatic antibiotics and associated resistance genes [20; Kiliç et al., Abstr. ASM Conf. Streptococcal Genet. (Genet. Streptococci, Enterococci, Lactococci)] may result in erroneous selection of surviving bacteria that do not have a cloned active promoter. Plasmids pMM223 and pMM225 carry the replication origin (ori) of the lactococcal plasmid pWV01 (three to five copies per cell in lactococci, streptococci, and Bacillus subtilis) (26). Because of their low copy number, these selection vectors are expected not to interfere significantly with regulation of gene expression in these gram-positive bacteria.
VS generally are refractory to electrotransformation. Weakening of cell walls by various methods, which increased transformation frequencies for several gram-positive bacteria (6, 22, 35, 36, 42), did not improve the transformation frequencies of our VS strains. With the optimized electroporation protocol, transformation frequencies appeared to increase almost linearly with increasing field strength and were maximal at 25 kV/cm (Fig. 2). At this maximum attainable field strength, only approximately 30% of the competent VS were killed. For E. coli, maximal transformation frequencies are obtained when 50 to 75% of the cells are killed due to the electrical discharge (11). Thus, even higher transformation frequencies might be possible with equipment capable of generating higher field strengths. S. gordonii CH1 and S. sanguis U108 had the highest transformation frequencies of the 15 strains tested. Plasmid size and possibly the plasmid-borne genes appeared to influence transformation efficiencies, as pMM223 and pMM225 had lower frequencies than pGKV210 in both S. sanguis U108 and S. gordonii CH1. Electroporation was superior to natural transformation of S. gordonii CH1 (Table 4), and frequencies were sufficiently high to construct a representative genomic bank.
Active promoters of S. gordonii CH1 could be detected using
the promoterless spectinomycin resistance gene of pMM223 and the kanamycin resistance gene of pMM225. Detection of the induced expression of the promoterless trp'-'lacZ in these plasmids
proved to be more difficult in our test strains, although this reporter gene has successfully been used in the closely related S. pneumoniae (5). S. gordonii CH1 harboring
pMM239, which carries the active rgg-gtfG promoter fragment
(46), could not be discriminated from S. gordonii
CH1 carrying pMM223 without a promoter, either on X-Gal-containing
plates or in agar overlays (1). Using the fluorescent
substrate FDG, elevated
-galactosidase levels in lysates of
bacterial clones harboring pMM239 could be recorded after 20 h
of incubation (Fig. 3). Although the
-galactosidase expression
of S. gordonii CH1 was subject to catabolite repression, as
demonstrated by reduction of expression in the presence of 2% glucose,
glucose did not improve discrimination between the presence and absence
of an active promoter. The use of a streptococcal mutant with lower
endogenous
-galactosidase activity, as described for S. pneumoniae (1), could be a suitable alternative.
Secondly, the E. coli lacZ gene might be replaced by
the recently described
-galactosidase gene of Bacillus
stearothermophilus [Poyart and Trieu-Cuot, Abstr. ASM Conf.
Streptococcal Genet. (Genet. Streptococci, Enterococci,
Lactococci)].
From an S. gordonii CH1 genomic library constructed in vector pMM223 a promoter fragment was isolated whose activity was upregulated by a shift from oral plaque pH (6.2) to blood pH (7.3). Part of this fragment showed homology to the promoter region of the hydA gene of C. acetobutylicum ATCC 824 (16), which encodes a putative hydrogenase with strong homology to the [Fe] hydrogenases from Desulfovibrio and other Clostridium species. The expression of C. acetobutylicum hydA is downregulated at the transcriptional level by a decrease in environmental pH (16). A more detailed study on the putative streptococcal promoter would be required to confirm its localization on the isolated fragment and determine the mode of transcription regulation. However, the activity of the promoter on the isolated fragment was clearly regulated by the environmental pH, showing that our selection method allows isolation of promoters responding to environmental changes.
In their study using an IVET chromosomal integration system, Kiliç and coworkers selected 13 inducible promoters from S. gordonii V288 in a rabbit model of IE. The genes controlled by the isolated promoters encode proteins involved in different cellular functions, including rapid bacterial growth and resistance to host defense [20; Kiliç et al., Abstr. ASM Conf. Streptococcal Genet. (Genet. Streptococci, Enterococci, Lactococci)]. A hydA promoter homolog as identified in our study was not among these selected promoters. The environmental stimuli responsible for induction of the identified inducible genes are still unknown.
To gain a more complete understanding of the regulation of expression of in vivo-induced genes, and of other virulence genes, it is crucial to identify the stimuli responsible for their induction. To our knowledge this report is the first one on the isolation of a VS promoter sequence whose activity is directly influenced by a shift from oral to blood pH. Such a stimulus might also be an important signal for gene induction in other bacterial species. We are presently studying whether the expression of more VS genes is influenced in response to this pH change and whether this response involves a common regulatory mechanism. These insights will possibly also contribute to a better understanding of the pathogenesis of IE.
| |
ACKNOWLEDGMENTS |
|---|
We thank Hilde Smith (ID-DLO, Lelystad, The Netherlands) for plasmid pORI19S, Elizabeth Campbell (Rockefeller University, New York, N.Y.) for plasmid pEC2A, and Horst Malke (Friedlich-Schiller-Universität, Jena, Germany) for providing the bidirectional transcriptional terminator from S. equisimilis H46A. We also thank Hilde Dijstelbloem for statistical analyses and Martine van Vugt for critically reading the manuscript.
| |
FOOTNOTES |
|---|
* Corresponding author. Present address: Department of Biotechnology, NUMICO Research, B.V., P.O. Box 7005, 6700 CA Wageningen, The Netherlands. Phone: 31 317 467 800. Fax: 31 317 466 500. E-mail: aldwin.vriesema{at}numico-research.nl.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Alloing, G., C. Granadel, D. A. Morrison, and J.-P. Claverys. 1996. Competence pheromone, oligopeptide permease, and induction of competence in Streptococcus pneumoniae. Mol. Microbiol. 21:471-478[CrossRef][Medline]. |
| 2. | Altschul, S. F., W. Gish, W. Miller, E. F. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410[CrossRef][Medline]. |
| 3. |
Baddour, L. M.
1994.
Virulence factors among gram-positive bacteria in experimental endocarditis.
Infect. Immun.
62:2143-2148 |
| 4. |
Bowden, G. H., and I. R. Hamilton.
1998.
Survival of oral bacteria.
Crit. Rev. Oral Biol. Med.
9:54-85 |
| 5. | Campbell, E. A., S. Y. Choi, and H. R. Masure. 1998. A competence regulon in Streptococcus pneumoniae revealed by genomic analysis. Mol. Microbiol. 27:929-939[CrossRef][Medline]. |
| 6. | Chassy, B. M. 1976. A gentle method for the lysis of oral streptococci. Biochem. Biophys. Res. Commun. 68:603-608[CrossRef][Medline]. |
| 7. |
Dall, L. H., and B. L. Herndon.
1990.
Association of cell-adherent glycocalyx and endocarditis production by viridans group streptococci.
J. Clin. Microbiol.
28:1698-1700 |
| 8. | Dankert, J., J. van der Werff, S. A. J. Zaat, W. Joldersma, D. Klein, and J. Hess. 1995. Involvement of bactericidal factors from thrombin-stimulated platelets in clearance of adherent viridans streptococci in experimental infective endocarditis. Infect. Immun. 63:663-671[Abstract]. |
| 9. |
de Lorenzo, V.,
M. Herrero,
U. Jakubzik, and K. N. Timmis.
1990.
Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria.
J. Bacteriol.
172:6568-6572 |
| 10. |
Douglas, C. W. I.,
J. Heath,
K. K. Hampton, and F. E. Preston.
1993.
Identity of viridans streptococci isolated from cases of infective endocarditis.
J. Med. Microbiol.
39:179-182 |
| 11. |
Dower, W. J.,
J. F. Miller, and C. W. Ragsdale.
1988.
High efficiency transformation of E. coli by high voltage electroporation.
Nucleic Acids Res.
16:6127-6145 |
| 12. | Durack, D. T., and P. B. Beeson. 1972. Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br. J. Exp. Pathol. 53:44-49[Medline]. |
| 13. |
Ebright, R. H.,
A. Kolb,
H. Buc,
T. A. Kunkel,
J. S. Krakow, and J. Beckwith.
1987.
Role of glutamic acid-181 in DNA-sequence recognition by the catabolic gene activator protein (CAP) of Escherichia coli: altered DNA-sequence-recognition properties of [Val181]CAP and [Leu181]CAP.
Proc. Natl. Acad. Sci. USA
84:6083-6087 |
| 14. | Evans, P. D., C. N. Cook, P. D. Riggs, and C. J. Noren. 1995. LITMUS; multipurpose cloning vectors with a novel system for bidirectional in vitro transcription. BioTechniques 19:130-135[Medline]. |
| 15. | Frandsen, E. V. G., V. Pedrazzoli, and M. Kilian. 1991. Ecology of viridans streptococci in the oral cavity and pharynx. Oral Microbiol. Immunol. 6:129-133[Medline]. |
| 16. |
Gorwa, M.-F.,
C. Croux, and P. Soucaille.
1996.
Molecular characterization and transcriptional analysis of the putative hydrogenase gene of Clostridium acetobutylicum ATCC 824.
J. Bacteriol.
178:2668-2675 |
| 17. | Gross, R. 1993. Signal transduction and virulence regulation in human and animal pathogens. FEMS Microbiol. Rev. 10:301-326[Medline]. |
| 18. |
Heithoff, D. M.,
C. P. Conner,
P. C. Hanna,
S. M. Julio,
U. Hentschel, and M. J. Mahan.
1997.
Bacterial infection as assessed by in vivo gene expression.
Proc. Natl. Acad. Sci. USA
94:934-939 |
| 19. |
Herzberg, M. C.
1996.
Platelet-streptococcal interactions in endocarditis.
Crit. Rev. Oral Biol. Med.
7:222-236 |
| 20. |
Herzberg, M. C.,
M. W. Meyer,
A. O. Kiliç, and L. Tao.
1997.
Host-pathogen interactions in bacterial endocarditis: streptococcal virulence in the host.
Adv. Dent. Res.
11:69-74 |
| 21. |
Hohn, B.
1979.
In vitro packaging of and cosmid DNA.
Methods Enzymol.
68:299-309[Medline].
|
| 22. |
Holo, H., and I. F. Nes.
1989.
High-frequency transformation, by electroporation, of Lactococcus lactis subsp. cremoris grown with glycine in osmotically stabilized media.
Appl. Environ. Microbiol.
55:3119-3123 |
| 23. | Jayaraman, G. C., J. E. Penders, and R. A. Burne. 1997. Transcriptional analysis of the Streptococcus mutans hcrA, grpE and dnaK genes and regulation of expression in response to heat shock and environmental acidification. Mol. Microbiol. 25:329-341[CrossRef][Medline]. |
| 24. |
Jenkinson, H. F.
1987.
Novobiocin-resistant mutants of Streptococcus sanguis with reduced cell hydrophobicity and defective in coaggregation.
J. Gen. Microbiol.
133:1909-1918 |
| 25. | Johnson, C. M. 1993. Adherence events in the pathogenesis of infective endocarditis. Infect. Dis. Clin. N. Am. 7:21-36[Medline]. |
| 26. |
Kok, J.,
J. M. B. M. van der Vossen, and G. Venema.
1984.
Construction of plasmid cloning vectors for lactic streptococci which also replicate in Bacillus subtilis and Escherichia coli.
Appl. Environ. Microbiol.
48:726-731 |
| 27. |
LeBlanc, D. J.,
L. N. Lee, and J. M. Inamine.
1991.
Cloning and nucleotide base sequence analysis of a spectinomycin adenyltransferase AAD(9) determinant from Enterococcus faecalis.
Antimicrob. Agents Chemother.
35:1804-1810 |
| 28. |
Mahan, M. J.,
J. M. Slauch, and J. J. Mekalanos.
1993.
Selection of bacterial virulence genes that are specifically induced in host tissues.
Science
259:686-688 |
| 29. | Marsh, J. L., M. Erfle, and E. J. Wykes. 1984. The pIC plasmids and phage vectors with versatile cloning sites for recombinant selection by insertional inactivation. Gene 32:481-485[CrossRef][Medline]. |
| 30. |
Mekalanos, J. J.
1992.
Environmental signals controlling expression of virulence determinants in bacteria.
J. Bacteriol.
174:1-7 |
| 31. | Munro, C. L., and F. L. Macrina. 1993. Sucrose-derived exopolysaccharides of Streptococcus mutans V403 contribute to infectivity in endocarditis. Mol. Microbiol. 8:133-142[Medline]. |
| 32. | National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. Approved standard M7-A4, 4th edition National Committee for Clinical Laboratory Standards, Wayne, Pa. |
| 33. | Nolte, W. A. 1982. Defense mechanisms of the mouth, p. 245-260. In W. A. Nolte (ed.), Oral microbiology. The C. V. Mosby Company, St. Louis, Mo. |
| 34. | Ohse, M., K. Takahashi, Y. Kadowaki, and H. Kusaoke. 1995. Effects of plasmid DNA sizes and several other factors on transformation of Bacillus subtilis ISW1214 with plasmid DNA by electroporation. Biosci. Biotechnol. Biochem. 59:1433-1437[Medline]. |
| 35. | Park, S. F., and G. S. Stewart. 1990. High efficiency transformation of Listeria monocytogenes by electroporation of penicillin treated cells. Gene 94:129-132[CrossRef][Medline]. |
| 36. |
Powell, I. B.,
M. G. Achen,
A. J. Hillier, and B. E. Davidson.
1988.
A simple and rapid method for genetic transformation of lactic streptococci by electroporation.
Appl. Environ. Microbiol.
54:655-660 |
| 37. | Pozzi, G., R. A. Musmanno, P. M.-J. Lievens, M. R. Oggioni, P. Plevani, and R. Manganelli. 1990. Method and parameters for genetic transformation of Streptococcus sanguis Challis. Res. Microbiol. 141:659-670[Medline]. |
| 38. | Quinn, F. D., G. W. Newman, and C. H. King. 1997. In search of virulence factors of human bacterial disease. Trends Microbiol. 5:20-26[CrossRef][Medline]. |
| 39. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 40. | Sandre, R. M., and S. D. Shafran. 1996. Infective endocarditis: review of 135 cases over 9 years. Clin. Infect. Dis. 22:276-286[Medline]. |
| 41. | Scheld, W. M., J. A. Valone, and M. A. Sande. 1978. Bacterial adherence in the pathogenesis of endocarditis. Interaction of bacterial dextran, platelets, and fibrin. J. Clin. Investig. 61:1394-1404. |
| 42. | Scott, P. T., and J. I. Rood. 1989. Electroporation-mediated transformation of lystaphin-treated Clostridium perfringens. Gene 82:327-333[CrossRef][Medline]. |
| 43. | Smith, H. 1996. What happens in vivo to bacterial pathogens. Ann. N. Y. Acad. Sci. 797:77-92[Medline]. |
| 44. |
Smith, H. E.,
H. J. Wisselink,
U. Vecht,
A. L. J. Gielkens, and M. A. Smits.
1995.
High-efficiency transformation and gene inactivation in Streptococcus suis type 2.
Microbiology
141:181-188 |
| 45. | Steiner, K., and H. Malke. 1995. Transcription termination of the streptokinase gene of Streptococcus equisimilis H46A: bidirectionality and efficiency in homologous and heterologous hosts. Mol. Gen. Genet. 246:374-380[CrossRef][Medline]. |
| 46. |
Sulavik, M. C.,
G. Tardif, and D. B. Clewell.
1992.
Identification of a gene, rgg, which regulates expression of glucosyltransferase and influences the Spp phenotype of Streptococcus gordonii Challis.
J. Bacteriol.
174:3577-3586 |
| 47. | Sullam, P. M. 1994. Host-pathogen interactions in the development of bacterial endocarditis. Curr. Opin. Infect. Dis. 7:304-309[CrossRef]. |
| 48. | Trieu-Cuot, P., and P. Courvalin. 1983. Nucleotide sequence of the Streptococcus faecalis plasmid gene encoding the 3'5"-aminoglycoside phosphotransferase type III. Gene 23:331-341[CrossRef][Medline]. |
| 49. |
Van de Guchte, M.,
J. M. B. M. van der Vossen,
J. Kok, and G. Venema.
1989.
Construction of a lactococcal expression vector: expression of hen egg white lysozyme in Lactococcus lactis subsp. lactis.
Appl. Environ. Microbiol.
55:224-228 |
| 50. |
Van der Vossen, J. M. B. M.,
J. Kok, and G. Venema.
1985.
Construction of cloning, promoter-screening, and terminator-screening shuttle vectors for Bacillus subtilis and Streptococcus lactis.
Appl. Environ. Microbiol.
50:540-542 |
| 51. | Voordouw, G., and S. Brenner. 1985. Nucleotide sequence of the gene encoding the hydrogenase from Desulfovibrio vulgaris (Hildenborough). Eur. J. Biochem. 148:515-520[Medline]. |
| 52. | Vriesema, A. J. M., S. A. J. Zaat, and J. Dankert. 1996. A simple procedure for isolation of cloning vectors and endogenous plasmids from viridans group streptococci and Staphylococcus aureus. Appl. Environ. Microbiol. 62:3527-3529[Abstract]. |
| 53. | Wells, V. D., C. L. Munro, M. C. Sulavik, D. B. Clewell, and F. L. Macrina. 1993. Infectivity of a glucan synthesis-defective mutant of Streptococcus gordonii (Challis) in a rat endocarditis model. FEMS Microbiol. Lett. 112:301-306[CrossRef][Medline]. |
| 54. | Young, M., N. P. Minton, and W. L. Staudenbauer. 1989. Recent advances in the genetics of clostridia. FEMS Microbiol. Rev. 63:301-326. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»